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Recombinant production of cell-penetrating peptides (CPPs) as fusions to protein “cargo” 
leads to low yields for some CPP-cargo fusions; thus, ways to enhance the recombinant 
expression of peptide-cargo fusions need to be identified. We optimized expression 
conditions for fusions of five CPPs (NPFSD, pVEC, SynB, histatin-5 and MPG) to the 
cargo proteins biotin carboxyl carrier protein (BCCP), maltose binding protein (MBP) 
and green fluorescent protein GFP. Glutathione-S-transferase was incorporated as a 
fusion partner to improve expression. In general, expression at 37 
o
C for 6 h and 10 h led 
 
to the highest levels of expression for the different CPP-cargo constructs. The fusion of 
histatin-5 to GFP was purified, and its translocation into the fungal pathogen Candida 
albicans was studied. The purified protein translocated into the nearly 3% of C. albicans 
cells. These results provide the foundation for future studies to improve translocation of 
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Chapter 1. Introduction 
 
 Fungal pathogens are a reason for concern as infections caused by them 
contribute to ill health and death in healthy and immunocompromised individuals 
suffering from AIDS, HIV, cancer and other illnesses 
8,9
. One of the most prevalent 
opportunistic fungal pathogens is Candida albicans
8,9
. Infection due to C. albicans 
can be fatal, and growing drug resistance has contributed to ineffective treatment
8,9
. 
Thus, new therapeutic approaches are needed. In considering new treatments, one 
important feature is the ability of new antifungal molecules to be effectively and 
specifically delivered across cell membranes to intracellular targets. 
 Over the years, numerous approaches have been recognized to deliver 
therapeutic agents through cellular membranes. These include microinjection, 
electroporation, and liposome and viral-based vectors
2,5
, but these methods have 
limitations like low efficiency, high toxicity, poor bioavailability and poor 
specificity
5
. Thus, an alternate approach is needed that could help solve these issues 
and help deliver non-cell permeable drugs to treat infections caused by C. albicans. A 
promising and novel approach for intracellular cargo delivery is the use of cell-
penetrating peptides (CPPs). CPPs are a class of peptides that can cross the 
phospholipid bilayer of the cell membrane
3,5
, and therefore, could be a potentially 
powerful option. CPPs like TAT and penetratin have been shown to effectively 
translocate through the cell membranes and enter cells
10-12
. CPPs are able to deliver 






cells. CPPs have shown translocation into C. albicans with molecular cargo, for 
example, NPFSD and Hst-5 can transport an N-terminal fluorescein isothiocyanate 
(FITC)
13,14 
 and NPFSD has also translocated GFP
13
. 
 In this study, we focused on enabling the use CPPs to deliver bioactive 
cargoes into Candida cells by better understanding how to produce CPPs fused to 
cargo at high levels.  
  
1.1 C. albicans 
 C. albicans is a commensal organism (lives in the body and causes no harm) 
and an opportunistic pathogen of humans that causes infections in the form of oral 
rashes and can lead to serious bloodstream infections as well as life-threatening 
disseminated and organ infections
9
. Pathogens such as C. albicans are of concern 
because of the growing occurrence of immunosuppression caused by AIDS, diabetes, 
cancer therapies, organ transplantation, and other conditions
9 
. 
 Antifungal agents like amphotericin B and fluconazole help treat candidiasis
15
 
but they can have toxic side-effects or infections can be resistant to them. For 
example, amphotericin B has severe toxicity to the kidneys
16
. In terms of resistance, 
the Centers for Disease Control and Prevention (CDC) lists fluconazole-resistant 
Candida species as a “serious threat” to public health and estimated an annual 
healthcare cost of $6000-$9000 for every infection 
17
. Antifungal resistance is a 
difficult issue mostly because the initial diagnosis of systemic fungal infection can be 
late and there are very few treatments available
16




amphotericin B-resistant C. albicans have been found in HIV-infected patients with 
prolonged treatment with azoles
18
. Because of the limitations of current antifungal 
agents and increasing resistance to these agents, new therapeutic approaches are 
needed to treat infections caused by C. albicans. This leads to our motivation to study 
cell-penetrating peptides (CPPs) that can act as potential drug delivery vehicles and 
help develop new treatments for candidiasis. 
 
1.2 Cell penetrating peptides 
 CPPs are known for their 
ability to cross membranes and have 
been shown as potential drug delivery 
vehicle for intracellular delivery of a 
diverse selection of bioactive cargoes 
that includes plasmid DNA, small 
interfering RNAs (siRNAs), proteins 
and peptides
1,3
 (Figure 1.1) inside cells for high levels of gene expression, gene 
silencing, or tumor targeting
1,5
. CPPs are short peptides, frequently positively charged 
or polar with several lysine or arginine residues in the sequence
3,5
 (Table 1). The 
polar/charged residues are often alternately arranged with non-polar/hydrophobic 
residues leading to an amphipathic secondary structure
19
. These flexible peptides are 
simple to synthesize, functionalize, and characterize
5
. The design of clinically 
Figure 1.1 Schematic representation of 
CPPs entering the cell membrane 




operational delivery systems involves design of both the delivered cargo and the CPP 
used to deliver it
5
.  
 There are many proposed models for cellular internalization of CPPs (Figure 
1.2). Uptake of the peptide–protein complex on the plasma membrane can be through 
endocytic or non-endocytic routes. 
Endocytic routes include receptor-based 
endocytosis like clathrin-mediated 
endocytosis, or non-receptor-based 
endocytosis like macropinocytosis. Using 
clathrin-mediated endocytosis, cells 
absorb proteins by the inward folding and 
budding of the plasma 
membrane vesicles enclosing proteins 
with receptor sites which are specific to the molecules being absorbed
20,21
.  
 Electron microscopy and biochemical studies show that endocytosis occurs 
via the nucleation of a clathrin-coated pit, including cargo capture and 
multimerization of clathrin followed by propagation of a coated pit involving 
membrane invagination and then is followed by budding or scission of the clathrin-
coated vesicle 
20,21
. This is followed by completion of the clathrin cage and the action 
of dynamin, and inside the cell, the coat disassembles and the uncoated vesicle is 
transferred to the target
20,21
. Macropinocytosis is a clathrin-independent endocytic 
mechanism that is induced for a very short time due to cell-surface receptor activation 
by specific cargoes 
22,23
. This process leads to formation of ruffles or protrusions and 
Figure 1.2 Schematic representation of 
proposed models and mechanisms for 
cellular internalization of CPPs (Adapted 






can collapse back onto the cell, entrapping fluid into vesicles called 
macropinosomes
20-22
. Non-endocytic routes are described by the inverted micelle 
model, the carpet model and the pore formation model. The inverted micelle model 
requires the CPPs to have hydrophobic amino acids that are essential for the 
translocation process. Electrostatic interactions between the CPP and negatively 
charged membrane phospholipids enables insertion into the membrane, and 
interaction between hydrophobic CPP residues and the membrane core led to 
formation of vesicles that captures the CPP
24
. The carpet model includes binding of 
the peptide with negatively charged phospholipids, followed by rotation of the 
peptide that allows interaction between hydrophobic residues of the peptide and the 
membrane
5
. This is followed by a disruption in the packing of the membrane thus 
allowing internalization of the peptide. Another model is the pore formation or barrel-
stave model that is due to formation of bundles by amphipathic α-helical peptides
5
. 
Pores form due to interaction between hydrophobic residues that face outward and 
hydrophilic surfaces that face inward, when the concentration of the peptides is 
higher than a specific threshold concentration that differs for each peptide.  
 The translocation of CPPs across a membrane depends on a number of factors. 
These factors include the specific sequence of the CPP, the concentration of CPP and 
the cell-type
24
. Additionally, the cargo that is fused to the CPP and the design of the 
CPP-cargo fusion may influence the method of translocation 
24,25
 For example, TAT 
has been suggested to use a caveolae-mediated endocytosis with protein cargo, but 
uses a clathrin-mediated delivery when attached to small molecules
21,25
. Caveolae are 




sphingolipids and can internalize large molecular complexes
21
. At high CPP 
concentrations of >10 μM direct penetration seems to be the predominant 
mechanism
5
. At low concentrations of CPPs, though, endocytosis is the main 
mechanism of uptake
5
 (Table 2). 
 CPPs have been used to deliver protein cargoes with various sizes ranging 
from 25 kDa to 150 kDa
26-28
. β-Galactosidase (120 kDa) has been delivered into 
mouse tissues, even in the brain, while maintaining its biological activity
29
. CPPs like 
TAT or penetratin have yielded substantial tissue localization (in mouse and rats) in 
vivo with antibody fragments as the cargoes
30
. Given their utility in delivering a range 
of cargo, further study of methods to improve their potential as therapeutics against 
C. albicans are warranted.  
 

















27 2807.36 +5 
31
 
NPFSD VLTNENPFSDP  11  1232.31 -2 
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35 3835.71 +12  
Histatin 5 DSHAKRHHGYKRKFH
EKHHSHRGY 









*Includes only charges due to amino acid side chains (pH 7) 
 
Table 2. Examples of CPPs, their structures and proposed mechanisms  
CPP Structure Proposed mechanism References 
































SynB β-sheet, α-helical Endocytosis 
33
 
MPG Amphipathic Endocytosis 
33
 




1.3 Challenges in production of CPP fusions  
 To enable delivery of protein cargo by CPPs, a method to link the protein and 
cargo is needed. Two main approaches exist: (1) chemical coupling of purified 
peptides to protein cargo and (2) recombinant production of a genetic fusion of a CPP 




to attach protein cargo to a peptide that has been synthesized and purified. There are 
various advantages of using the chemical coupling method. Peptide toxicity to cells is 
not an issue, and any cargo (commercial or recombinant) can be attached. Another 
advantage of this method is the availability of different methods of conjugation to 
cargo. Each protein and peptide comprises of various amino acids with different 
sequences and thus availability of the reactive groups is abundant. Most important 
amino acids that can be used for modification and conjugation purposes, as they 
contain ionizable side chains are aspartic acid, glutamic acid, lysine, arginine, 
cysteine, histidine, and tyrosine. Derivatization of the side chain sulfhydryl of 




 Although chemical coupling has some advantages, it also has important 
limitations. The peptide synthesis itself is one limitation, due to the high cost, the 
time lag from ordering the peptide commercially to receive it (3 weeks or more).  The 
commercially synthesized peptides may lack a carboxyl group thus making it difficult 
to chemically conjugate it to a protein cargo. Additionally, although the number of 
available reactive groups in proteins and peptides is an advantage in terms of 
versatility, it also makes site-specific conjugation of peptides to protein cargo 
challenging. 
 Rather than using chemistry approaches to couple CPPs and cargo, 
recombinant protein production techniques can be used. Advantages of such a 
technique are many. They are less costly, allow easy control of cargo fusion to N- or 




are already well established for production in E. coli. Recombinant protein expression 
of CPPs as fusions to protein cargo is a promising approach, but it still can present 
various challenges. One challenge is that of no or low expression, which could be due 
to toxicity of the peptides and proteins before or after induction could be solved by 
addition of glucose, controlling the level of induction and codon bias can be solved 
by optimization of codon frequency
37
. Optimization of temperature and induction 





potential challenge is that of inclusion body formation which could be due to 
incorrect disulfide bond formation, incorrect folding or low solubility of the CPP-
cargo fusion protein. Using E. coli strains with oxidative cytoplasmic environment, 
co-expressing the protein along with molecular chaperones or using a fusion to a 
solubility enhancing protein could help alleviate the problems
37
. Protein inactivity 
due to incomplete folding or mutations in the cDNA could be other possible issues 
during recombinant protein production
37
. The fusion may not be sufficiently soluble 




1.4 Overview of thesis 
 This thesis describes the work to produce CPP-cargo fusions and optimize 
their expression. Various strategies to enhance production need to be applied, and we 
believe the combination of right peptide and the right cargo size, linkers and the 
perfect soluble partner should enable us to achieve targeted drug delivery. In Chapter 




study. I describe in detail the characteristic features of all the CPPs (NPFSD, pVEC, 
SynB, histatin-5 and MPG) and cargoes (BCCP, GFP and BCCP) used. In Chapter 3, 
I describe the detailed experimental methods and the materials used for expression 
and translocation studies. In Chapter 4, I present my results of the experiments 
evaluating various expression conditions and fusion designs. In Chapter 5, I describe 
the purification of a CPP-cargo fusion for preliminary translocation experiments into 
C. albicans. Finally, my conclusions and recommendations for future work are 














Chapter 2. Design of constructs 
 
 To study the expression of CPP 
fusions to cargo, we designed a 
modular system that includes a CPP 
genetically fused to a protein cargo 
(Figure 2.1). A modular design ensures 
that the CPPs and the cargoes can be easily exchanged. A glycine-serine linker (G4S) 
was included to improve expression, since it was previously found to be effective in 
enhancing soluble protein expression
13,40
. This flexible linker allows interaction 
between domains or can increase the separation between domains thus allowing 
flexibility
41
. Glutathione-S-transferase (GST) was included as a fusion partner at the 
N-terminus or C-terminus in the constructs to evaluate its effect on expression. GST 
has been used as a fusion partner since it enhances expression
37
. GST can also act as 






 We selected several CPPs to study in our system: NPFSD, pVEC, SynB, 
histatin-5 and MPG. These peptides were selected because they had been previously 
shown to be translocated into C. albicans
13,31
 and thus they look promising for future 
Figure 2.1. Fusion constructs designed for 
this work with the fusion partner at the (a) 




studies of translocation of protein cargo. They have varied mechanisms and properties 
(Table 1 & 2 in Chapter 1). 
2.1.1 SynB 
 SynB (RGGRLSYSRRRFSTSTGR) is a CPP obtained from the antimicrobial 
peptide (AMP) protegrin 1 (PG-1), an 18 amino acid peptide initially isolated from 
porcine leukocytes
33
. Numerous linear analogues of PG-1 without cysteine residues 
were designed to remove cyclization and prevent pore formation. The linear SynB 
peptide interacts with the cell surface and crosses the plasma membrane but does not 
disrupt the membrane. It was suggested that SynB adopts an energy-dependent 




2.1.2 Histatin 5 
 Hst-5 which is found in human saliva, is an important component of the 
human immune system due to its candidacidal and to some extent bactericidal 
effects
45-48
. Hst-5 is effective in killing both the yeast and hyphal forms of C. 
albicans
46
. The killing process involves binding to the cell membrane of C. albicans, 
translocating into the cytoplasm and then targeting the mitochondria to lead to both 
membrane damage and cell death
47,49,50
. Unlike many other AMPs, membrane 
disruption alone is not responsible for the fungicidal activity of Hst-5 and it must 
cross the cell membrane to exert its activity
14,45-50
. Thus, although it is best known for 







 MPG is a short 
amphipathic peptide
7
 (Figure 2.2). 
It consists of three domains: an N-
terminal hydrophobic motif; a 
hydrophilic lysine-rich domain 
derived from the nuclear localization sequence (NLS) of the SV40 (simian virus 40) 
large T-antigen (KKKRKV) that is necessary for interaction with nucleic acids and 
cellular uptake, intracellular trafficking of cargo and solubility of the peptide vector; a 
linker domain (WSQP) between the two other domains, which contains a proline 
residue to improve flexibility and the integrity of both the hydrophobic and 
hydrophilic domains
7
. MPG can form stable nanoparticles with protein cargoes 
without any cross-linking or chemical modifications
7
, though we will use it 
covalently linked to cargo for consistency with our other peptides. MPG (either 
bound to or free of cargo), has been shown to strongly interact with membrane lipids 





 The peptide NPFSD was originally found as an endocytosis signal in 
Saccharomyces cerevisiae
34,35
, and this signal sequence can transport both large and 
Figure 2.2 Sequence alignment and secondary 
structure of MPG; residues involved in cargo 
binding and cellular uptake are in red and yellow 
respectively. (Adapted from Morris et al.)
7
.  
MPG sequence is acetylated at the N-terminus and 
a cysteamide group at the C-terminus; these are 





small molecules into S. cerevisiae and C. albicans
13,34,35





 pVEC is a peptide that 
originates from a murine vascular 
endothelium (VE)-cadherin. pVEC 
contains a sequence of 18 amino 
acids, out of which 13 amino acids 
are from the cytosolic domain of 
VE-cadherin closest to the 
membrane and 5 amino acids are 
from the C-terminus of the 
transmembrane region of VE-
cadherin
2
(Figure 2.3).  
 The presence of four arginine residues and two lysine residues gives pVEC its 
positive charge. The N-terminus of the pVEC sequence is hydrophobic, with a 
charged middle part and a hydrophilic C-terminus. Clathrin-dependent endocytosis 







Figure 2.3 Schematic representation of the origin 
of pVEC from amino acids that traverse the 
transmembrane part to the cytosolic tail of the 







2.2 Protein cargoes 
 Three cargoes were included in our constructs to provide a variety of sizes: 
biotin carboxyl carrier protein (BCCP, 10 kDa), maltose-binding protein (MBP, 42 
kDa) and green fluorescent protein (GFP, 27 kDa) (Table 3). This will ultimately 
offer the opportunity to explore whether there is a size limitation in translocation. All 




Table 3. Protein cargoes  














































2.2.1 Biotin carboxyl carrier protein 
 E. coli acetyl-CoA carboxylase (ACC) catalyzes the first step of fatty acid 
synthesis, to form malonyl-CoA
52
. For these 
reactions, ACC needs two protein subassemblies, 
biotin carboxylase (BC) and carboxyl-transferase 
(CT). A third protein, BCCP (Figure 2.4), is 
known to carry the biotin cofactor covalently 
bound to the lysine residue. All three ACC 
proteins in E. coli form a complex.  Previous 
studies demonstrate that biotinylation stabilizes 
E. coli BCCP. BCCP is inherently produced by 
E. coli and is also a small-sized protein, thus making it a suitable choice for our 
expression studies. 
 







FIGURE 2.4 Biotin carboxyl 
carrier protein (pyruvate 
carboxylase (PC) tetramerization 
(PT) and carboxyltransferase 




FIGURE 2.5 Green fluorescent 
protein from Aequorea victoria 
(Adapted from Ormo et al., 
1996)
4




 GFP is a protein with 238 amino acid residues (26.9 kDa; Figure 2.5). It 
absorbs blue light at 395 nm with a minor peak at 470 nm and exhibits bright green 
fluorescence at 509 nm
4,57
. The green fluorescence is stable and almost no photo 
bleaching is seen
57
. This protein has been selected due to its fluorescence property, 
which will help us to study the translocation into cells when it is fused to an 
appropriate CPP. At the same time, the choice is fitting, since it is bigger in size 
compared to BCCP but smaller than MBP. 
 
2.2.3 Maltose-binding protein 
 E. coli MBP is a 370 amino acid protein 
(42 kDa) with an ellipsoidal structure that is 
divided into distinct globular structures separated 
by a deep groove (Figure 2.6). Each domain is 
built from amino- and carboxyl-terminal halves, 
and both domains show similar supersecondary structure, consisting of a central α-
pleated sheet flanked on both sides with parallel α-helices
59
. E. coli MBP is soluble in 
the E. coli cytoplasm, and its binding to amylose resin can be used to aid in its 
purification 
53,54
. MBP does not have any cysteine residues so it cannot affect the 
formation of disulfide bonds with the CPPs in our fusion constructs
54
. MBP has been 
chosen as a model cargo since it is a soluble partner and is a large sized protein, thus 
allowing us to study the size-limitation in translocation studies. 
 
FIGURE 2.6 Maltose binding 






Chapter 3. Methods and materials 
 
3.1 Plasmid construction 
 We used recombinant cloning techniques to produce CPP-cargo fusion 
complexes. Plasmids containing MBP, GFP and BCCP and their genetic fusions to 
NPFSD, pVEC, SynB, MPG and Hst-5 were constructed based on the pET21a and 
pET-42a vectors (Novagen). Plasmids used in this work are described in Table 4. 
3.1.1 pNGST and pCGST vectors 
The pCGST and pNGST vectors differ mainly by the position of their soluble fusion 
partner, GST. The pCGST design has a C-terminal GST whereas pNGST has an N-
terminal GST. This change in design is suggested because it is believed that with the 
soluble partner at the N-terminus, the construct will fold properly during expression. 
 The pCGST plasmids were designed based on the pET-21(a) vector with the 
N-terminal T7 tag (Figure 3.1). The pET-42a vector has glutathione-S-transferase 
(GST) attached as a fusion partner. GST was PCR amplified using NotI-Ala-KpnI-
GST-F and GST-XhoI-R, and inserted into pET-21 digested by NotI and XhoI, 
resulting in pGST. FLAG tag and TEV cut-sites were created by oligonucleotides 
dimer insertion with NotI-FLAG-HindIII-F/NotI-FLAG-HindIII-R, and HindIII-
TEV-KpnI-F/HindIII-TEV-KpnI-R. Two primer dimers were inserted into pGST 





 The pNGST plasmid was constructed with pET-21(a) as the backbone and 
GST from the pET-42a vectors on the N-terminus (Figure 3.2).  The GST fusion 
partner was first amplified using the primers BamHI-GST-F and GST-EcoRI-R and 
inserted into pET-21(a) with BamHI and EcoRI digestion. To allow removal of the 
GST, a Factor Xa cleavage site (ATTGAGGGACGC) was also included. 
Figure 3.1 Plasmid map of pCGST. This plasmid has been designed with appropriate 
cut sites. pCGST21 was designed based on pET-21(a) vector with the N-terminal T7 tag. 
The plasmid map shows the cut sits for the insertion of the peptides (EcorI and SacI) and 







3.1.2 Construction of fusion constructs 
 Plasmids containing various combinations of peptides (or no peptide) and 
cargo proteins (Table 4) were constructed in pCGST (NPFSD and pVEC) and 
pNGST (SynB, Hst-5 and MPG).  
 Plasmids containing BCCP and genetic fusions of NPFSD to BCCP were 
created using the pCGST plasmid for expression with a C-terminal GST tag. All 
primers are listed in Table 3. DNA encoding BCCP with an N-terminal NPFSD and 
pVEC peptide were amplified using a PCR reaction with a forward primer that 
Figure 3.2 Plasmid map of pNGST. The pNGST plasmid was constructed with 
pET-21(a) as the backbone and GST from the pET-42a vectors on the N-terminus 
(Figure 3.2).  6XHis site is also shown with an N-terminal GST followed by the 
cut sites for the insertion of the peptides (EcorI and SacI) and the cargoes (SacI 




contained the peptide sequence followed by a C-terminal G4S peptide linker 
sequence or followed by no linker sequence (Table 3) and with the reverse primer 
BCCP-NotI-R. These PCR products were then introduced between the EcoRI and 
NotI sites of the pCGST plasmid forming the plasmids pCGST-CPP-G4S-BCCP and 
pCGST-CPP-BCCP, where the CPP was either NPFSD or pVEC). 
 Peptides were inserted into the pNGST plasmid for expression with an N-
terminal GST tag using pairs of annealed oligonucleotides. The pairs of 
oligonucleotides also contained the coding sequence for proteolytic cleavage by 
Factor Xa. The oligonucleotide pairs were synthesized commercially to result in 
EcoRI and SacI sticky ends upon annealing to form dimers (SynB: Xa-SynB-top-1 
and Xa-SynB-bottom-1; Xa-SynB-top-2 and Xa-SynB-bottom-2; Xa-SynB-G4S-top 
and Xa-SynB-G4S-bottom) (Table 3). For example, the pairs EcoRI-FactorXa-MPG-
Top1 and EcoRI-FactorXa-MPG-Bottom1, and the pairs SacI-G4S-MPG-Top2 and 
SacI-G4S-MPG-Bottom2 were annealed to form the MPG dimers. These dimers were 
inserted between the EcoRI and SacI sites of pNGST. 
 The DNA encoding the cargoes was PCR-amplified from template plasmids in 
our lab stocks using the primers SacI-[Cargo]-F and [Cargo]-NotI-R (Table 3), where 
[Cargo] represents MBP, GFP and BCCP. The resulting products were inserted 








Table 4. Oligonucleotide sequences  
Oligonucleotide 
sequence name 






















































































Xa-SynB-top-2 GGTTCTCCACTTCCACGGGCCGTGAGCT This study 
Xa-SynB-bottom-
2 














































































NPFSD-Bottom-1 ACGGGTTTTCGTTGGTCAGCACA This study 
NPFSD-top-2 CCGTTTTCTGATCCGTGATGAC This study 












Table 5. Plasmids used in this study 
Plasmid Name Backbone CPP Linker  Cargo 
pCGST-NPFSD-BCCP pCGST NPFSD No BCCP 
pCGST-NPFSD-G4S-
BCCP 
pCGST NPFSD Yes BCCP 
pCGST-pVEC-BCCP pCGST pVEC No BCCP 
pCGST-pVEC-G4S-BCCP pCGST pVEC Yes BCCP 
pNGST-SynB-MBP pNGST SynB No MBP 
pNGST-SynB-G4S-MBP pNGST SynB Yes MBP 
pNGST-SynB-G4S-GFP pNGST SynB Yes GFP 
pNGST-SynB-G4S-BCCP pNGST SynB Yes BCCP 
pNGST-Hst-5-G4S-MBP pNGST Hst-5 Yes MBP 
pNGST-Hst-5-G4S-GFP pNGST Hst-5 Yes GFP 
pNGST-Hst-5-G4S-BCCP pNGST Hst-5 Yes BCCP 
pNGST-MPG -G4S-MBP pNGST MPG Yes MBP 
pNGST-MPG -G4S-GFP pNGST MPG Yes GFP 
pNGST-MPG-G4S-BCCP pNGST MPG Yes BCCP 
pNGST-MBP pNGST - - MBP 
pNGST-GFP pNGST - - GFP 








 All plasmid construction was done using E. coli DH5α (Novagen). Following 
successful plasmid construction, plasmids were transformed into E. coli BL21 (DE3) 
(Novagen) for all expression studies. BL21 (DE3) is the most extensively used E. coli 
strain for high-yield expression of recombinant proteins and uses the promoter 
selectivity and transcriptional action of the T7 RNA polymerase
63
. 
 To compare expression between fusion constructs with different cargoes and 
CPPs, 25 mL of overnight culture for each construct was sub-cultured into 400 mL of 
fresh Luria Bertani (LB) broth (10 mg/mL tryptone, 5 mg/mL yeast extract and 5 
mg/mL NaCl) at an optical density of OD600 = 0.05  and grown at 37 °C for 2 h. After 
incubation, the culture was aliquoted into three 100 mL cultures. Expression of the 
fusion proteins  was then induced by adding isopropyl β-D-1-thiogalactopyranoside 
(IPTG, Fisher BioReagents) to each culture aliquot at a final concentration of  0.01 
mM. The three separate cultures were then incubated at 37 °C, 30 °C or 20 °C, and 
samples were aliquoted from each flask at 6 h, 10 h and 24 h. For the BCCP 
constructs, biotin was added at 5 mM along with IPTG to allow detection of BCCP 
via the biotin modification. 
3.3 Protein expression level examined by Western blot 
 The expression level of the peptide-cargo fusions at different conditions was 
compared using Western blotting. Following induction of the protein fusions, the 
cells in each culture were pelleted by centrifugation at 4300×g for 15 min at 4 °C and 
lysed with BugBuster Master Mix (EMD Millipore) according to the manufacturer’s 




were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) on 7.5% Mini-PROTEAN® TGX™ gels for MBP fusion constructs or Any 
kD™ Mini-PROTEAN® TGX™ gels for the remaining constructs (Bio-Rad). 
Standard Western blotting protocols were used to transfer and detect the proteins. 
Briefly, separated proteins were transferred to a polyvinyl difluoride (PVDF) 
membrane and stained with the horseradish peroxidase (HRP)-conjugated anti-6X His 
tag antibody (Abcam) and/or HRP-conjugated anti-GST antibody (Abcam) to 
compare expression levels. The BCCP constructs were stained with an HRP-
conjugated anti-biotin antibody (Abcam) for detecting the biotinylated protein 
cargoes.  After staining the membranes, the images were developed using Clarity 
Western ECL Substrate (Bio-Rad), and the chemiluminescence was imaged on a 
ChemiDoc MP documentation system (Bio-Rad). Western blots were performed for 
three independent biological replicates for each construct. 
3.3.1 Densitometry analysis 
 Densitometry analysis was done on the Western blots to assess the relative 
expression level based on the signal of the detected bands. Densitometry analysis of 
all gels was done using ImageLab software (Version 5.2; Bio-Rad). The software 
reads the raw data in three dimensions by using the length and width of the band. The 
chemiluminescent signal emitted from the blot is recorded in the third dimension as a 
peak. The density of any given band was quantified as the total volume under the 
three-dimensional peak. Within the expression data for each construct, the data were 




intensities of all samples. A one-way (for Figure 4.9) and two-way (all other data) 
ANOVA analysis (GraphPad Prism 7.03) was used for statistical analysis to calculate 
the statistical significance of each data point across each induction time and each 
temperature.  
 
3.4 Protein purification 
 The Hst-5-G4S-GFP fusion construct was purified for translocation studies. A 
culture of 500 mL of BL21 (DE3) cells containing pNGST-Hst-5-G4S-GFP was 
incubated at 37 °C for 6 h. Following harvesting of the cells by centrifugation, the 
cells were resuspended in the buffer for purification (125 mM Tris (pH 7.5), 150 mM 
NaCl, 1 mM EDTA). The cells were then lysed using a homogenizer cell disruption 
system (Avestin). After lysis of each sample, the whole-cell lysates were pelleted by 
centrifugation at 11,400×g for 50 min at 4 °C, and the supernatants containing the 
soluble fraction of the cell lysates were collected.  
 The soluble fraction of each lysate was passed through a 0.2 μm filter and 
applied to an IMAC Profinity Ni-NTA resin column (Bio-Rad). After thoroughly 
washing the column, Factor Xa (10 µL) was added to the column, and the column 
was shaken overnight to cleave the GST expression partner from the constructs bound 
to the column. After overnight incubation, the flow-through and washes were 
collected. GFP and Hst-5-G4S-GFP were eluted in a buffer containing 20 mM sodium 




 For downstream ion-exchange purification to remove the Factor Xa, the 
elution was dialyzed against 20 mM imidazole and applied to an Enrich-Q anion-
exchange column (Bio-Rad) attached to an NGC liquid chromatography system (Bio-
Rad). The bound Hst-5–G4S–GFP fusion protein was washed with 5 column volumes 
of 20 mM imidazole and eluted by applying a gradient of NaCl, from 10% to 40% 
over 25 min. Following ion exchange, the purified proteins were dialyzed against 10 
mM sodium phosphate buffer (NaPB) to further prepare for translocation studies.  
 The product at each step of the purification was stored at 4 °C, and the total 
protein concentration was estimated using a NanoDrop instrument (Thermo 
Scientific) to measure the absorbance at 280 nm. SDS-PAGE was used to estimate 
protein purity. Samples from each step of the purification (lysate, washes and elutes) 
were normalized by culture volume, and separated by SDS-PAGE on Any kD Mini-
PROTEAN TGX gels. The protein gels were stained with Bio-Safe Coomassie stain 
(Bio-Rad) and imaged on the ChemiDoc MP documentation system. For quantifying 
the yield of purified protein, three biological replicates (three separate cultures) were 
prepared on three separate days.   
 GFP was produced using the pET21-GFP plasmid (construct lacked 
GST)
13
and purified using both IMAC and IEX to further use the purified product for 
translocation studies. 
3.5 Candida strain and culture conditions 
 The C. albicans clinical isolate strain SC5314 (American Type Culture 




into 5 mL of yeast–peptone–dextrose (YPD) liquid medium (1 % yeast extract, 2 % 
peptone and 2 % glucose) from an YPD agar plate (1 % yeast extract, 2 % peptone, 2 
% glucose and 2 % agar). The liquid culture was then grown overnight at 30 °C while 
shaking at 230 rpm. The cells in the overnight culture were subcultured into 5 mL of 
fresh YPD medium at an OD600 = 0.1 (approximately 2 × 10
6
 cells/mL). The culture 
was then grown at 30 °C to OD600 = 0.5 (approximately 1 × 10
7
 cells/mL) while 
shaking. Cells were harvested by centrifugation at 4000×g at 4 °C for 10 min and 




3.6 Cellular uptake studies using flow cytometry 
 A solution of purified GFP or Hst5-G4S-GFP (100 µL of each, 1 µM) was 
made in 10 mM NaPB, mixed with 100 µL of cell suspension that contained 5×105 
cells in 10 mM NaPB and incubated at 30 °C for 1 h. Cells were pelleted by 
centrifugation at 5,000 ×g for 10 min at 4 °C and washed with 10 mM NaPB. The cell 
pellet was then incubated with 200 µL of trypsin (Invitrogen) at 37 °C in a water bath 
for 5 min to remove surface-bound protein
64
. After trypsin treatment, cells were 
washed with 200 µL of 10 mM NaPB and re-suspended in 250 µL of 10 mM NaPB. 
The intracellular fluorescence level of GFP was quantified by flow cytometry (BD 
FACSCantoII). Single cells were selected and the percentage of GFP fluorescence-
positive cells was used to evaluate the translocation efficacy. To examine the 




the suspension to a final concentration of 0.1 mg/ml before flow cytometry 
measurement. Three replicates were performed and consisted of three different 
batches of purified protein samples being incubated with three separate cell cultures 






Chapter 4. Expression optimization studies 
 
4.1 Objective of expression studies 
 Our goal was to evaluate the recombinant expression of genetic fusions of 
CPPs to protein cargoes to identify optimal expression conditions for the fusions and 
determine whether a standardized set of expression conditions can be used. We 
evaluated five CPPs (NPFSD, pVEC, SynB, Hst-5 and MPG) and three cargoes 
(BCCP, GFP and MBP). These CPPs and cargoes allowed us to explore whether 
expression conditions can be generalized for a variety of constructs. We also explored 
the utility of including a flexible G4S linker in constructs containing the soluble 
fusion partner GST (at the N-terminus or C-terminus). Gong and Karlsson previously 
showed that the linker helped in expression of NPFSD constructs genetically fused to 
GFP, without reducing translocation into the fungal pathogen C. albicans or affecting 




4.2 Effect of linker on expression in constructs containing GST 
 NPFSD and pVEC have shown translocation into C. albicans with molecular 
cargo. For example, NPFSD can transport an N-terminal fluorescein isothiocyanate 
(FITC)
14
, C-terminal green fluorescent protein (GFP)
13
, and C-terminal ricin A chain 
toxin into the cytosol of C. albicans
35




carboxyfluorescein and C-terminal GFP into C. albicans
13,65
. These CPPs thus were a 
perfect starting point for improving recombinant expression. 
  GST was fused to the C-terminus to allow enhancement in expression, 
because earlier attempts to express these constructs resulted in low yields
13
. A 6XHis 
tag was included in the constructs to allow detection by Western blotting. While 
evaluating the effect of the linker, we also expressed the constructs at various 
temperatures and induction times to concurrently evaluate expression conditions. 
 To study the significance of the linker on expression of CPP–cargo protein 
fusions, the NPFSD and pVEC were genetically fused to BCCP with and without a 
G4S linker between the CPP and BCCP (Figure 4.1). Temperatures of 37 °C and 20 
°C and induction times of 4 h, 6 h, 8 h, 10 h and 24 h were chosen to evaluate a 
variety of conditions in which to express our fusion constructs in E. coli BL21(DE3) 
cells. The soluble cell lysate was analyzed by Western blotting.
 
 Expression results varied depending on the construct. We first evaluated 
expression at 20 °C and 37 °C for 8 h and observed better expression at 37 °C 
compared to 20 °C for the NPFSD constructs (Figure 4.2). However, pVEC-G4S-
BCCP-GST failed to express well at either temperature (Figure 4.2).  
BCCP NPFSD 







Figure 4.1 Design of CPP-BCCP constructs with a C-terminal GST and with or without a 











 We then evaluated expression of the constructs at induction times ranging 
from 4 h – 24 h at 37 °C and still did not observe substantial expression of the pVEC 
constructs (Figure 4.3). This poor expression could be due to the fact that pVEC 
shows antimicrobial activity
13,32
, and the intracellular accumulation of pVEC fusions 
results in insoluble expression or even cell death. For NPFSD constructs, the data for 
induction times of 4 h – 24 h (Figure 4.3) showed no significant expression at 4 h and 
obvious degradation at 24 h.  For this reason, 4 h was not included in subsequent 
experiments to evaluate the effect of the linker.
 
Figure 4.2 Expression of CPP-G4S-BCCP-GST and CPP-BCCP-GST at 
different temperatures. CPP fusions to BCCP were expressed in BL21(DE3) 
cells at 37 °C  and 20 °C at 8 h with 0.01 mM IPTG. The soluble cell lysate was 
analyzed by Western blotting, with samples normalized by culture volume. 
Proteins were detected using an anti-His antibody. Molecular weights of fusion 
proteins are as follows: NPFSD-BCCP-GST = 36.7 kDa; pVEC-BCCP-GST = 






 The addition of a linker did not enhance expression for these constructs as it 
did previously
13
. Densitometry analysis of expression data at 4, 6, and 8 h for the 
NPFSD constructs showed that the constructs without the linker were similar to those 
with the linker (Figure 4.4), and no statistically significant effect of the linker (or the 
induction time) was observed. Several differences between the constructs in this study 
and those in the previous study may contribute to this discrepancy. The two major 
differences are the cargo protein (BCCP in this study vs. GFP in the previous study) 
and the presence of the solubility enhancer GST in the current study. This suggests 
that fusion proteins—either solubility enhancer or cargo proteins—may play a larger 
role in expression than the linker. Thus, to see how a different cargo affects the 
expression, we compared between different combinations of cargoes and peptides. 
Although the addition of a linker had no clear positive or negative effect on 
Figure 4.3 Expression of CPP-G4S-BCCP-GST and CPP-BCCP-GST at different 
induction times. CPP fusion to BCCP was expressed in BL21 (DE3) cells at 37 °C for 4 
h, 6 h, 8 h and 24 h with 0.01 mM IPTG. The soluble cell lysate was analyzed by 
Western blotting, with samples normalized by culture volume. Proteins were detected 
using an anti-His antibody. Molecular weights of fusion proteins are as follows: NPFSD-
BCCP-GST = 36.7 kDa; pVEC-BCCP-GST = 37.6 kDa; NPFSD-G4S-BCCP-GST= 37.3 





expression for the fusion constructs, subsequent studies have included the linker 
between the CPP and cargo due to its positive effect in the previous study.  
 
4.3 Expression of CPP constructs with MBP as the cargo 
 One cargo protein that we 
evaluated was MBP, the well-
known solubility enhancer. MBP  
is the largest cargo protein we evaluated. Each of the MBP constructs, as well as the 
constructs for the other cargo proteins, included GST at the N-terminus, a G4S linker 
Figure 4.4 Quantification of expression of NPFSD-G4S-BCCP-GST and NPFSD-
BCCP-GST at different induction times. CPP fusions to BCCP were expressed in 
BL21 (DE3) cells at 37 °C for 6 h, 8 h and 10 h with 0.01 mM IPTG. The soluble cell 
lysate was analyzed by Western blotting, with samples normalized by culture volume. 
The Western blot was stained using an (A) anti-His (mouse) primary antibody and (B) 
an anti-biotin HRP-conjugated anti-mouse antibody (to confirm biotinylation). (C) The 
Western blot data were quantified by densitometry, and the error bars represent the 
standard error of the average of three biological replicates (N=3). In this case neither 
the temperature nor the addition of a linker was statistically significant. Refer to Figure 
A7 in Appendix A for raw data. Molecular weights of fusion proteins are as follows: 





Figure 4.5 Design of constructs with CPP 
fused to cargo.  
  




between the CPP and cargo, and a C-terminal 6XHis tag. Our previous constructs 
(with GST at the C-terminus) showed expression, but other work in our lab showed 
that moving the soluble partner to the N-terminus allows better expression, consistent 
with the standard location in the literature
66
.The peptides chosen here were SynB, 





. The expression of the CPP-cargo fusions was evaluated at 
induction temperatures of 20 °C, 30 °C and 37 °C and induction times of 6 h, 10 h 
and 24 h to cover a wide range. Following Western blotting to detect expression of 
the fusion proteins, the expression level was quantified by densitometry.  
4.3.1 Expression of GST-SynB-G4S-MBP  
 The expression of the fusion construct containing SynB and MBP was 
evaluated at different expression conditions (Figure 4.6). This construct expressed 
well at all temperatures and induction times, as the strong band at about the size of 
the GST-SynB-MBP-G4S fusion (70.2 kDa). The relative expression level confirmed 
that expression at 37 
o
C and 6 h and 10 h was better than at 24 h (p ≤ 0.01). At 6 h, 
both the constructs at 37 
o
C and 30 
o
C expressed better than those at 20 
o
C (p ≤ 0.05 
and p ≤ 0.001 respectively). 37 
o
C expressed better than 20 
o
C at 10 h (p ≤ 0.05) and 
37 
o
C expressed better than both 30 
o
C and 20 
o
C at 24 h (p ≤ 0.05). For this 
construct, both temperature and induction time was significant for expression (p ≤ 
0.01), with 37 
o


















Figure 4.6 Expression of GST-SynB-G4S-MBP. CPP fusion to MBP was expressed in 
BL21 (DE3) cells at 37 °C, 30 °C and 20 °C for 6 h, 10 h and 24 h with 0.01 mM IPTG. 
The soluble cell lysate was analyzed by Western blotting, with samples normalized by 
culture volume. The Western blot was stained using an (A) HRP-conjugated anti-GST 
antibody. (B) The Western blot data were quantified by densitometry, and the error bars 
represent the standard error of the average of three replicates (N=3). Both temperature and 
induction time had a statistically significant effect (p<0.01). Refer to Figure A1 in 









4.3.2 Expression of GST-Hst-5-G4S-MBP  
 The construct containing MBP with the CPP Hst-5 was also evaluated. The 
expected size for this constructs is 71.1 kDa (GST-G4S-Hst-5-MBP), and it expressed 
well at all expression conditions (Figure 4.7). The highest level of expression 
occurred at 37 
o
C and 6 h (Figure 4.7). While expression of the constructs at 37 
o
C 
was higher at 6 h than 10 h or 24 h (p≤ 0.05 & p≤0.01 respectively), induction time 
did not have a significant effect on expression at 30 
o
C or 20 
o
C, whereas for 6 h  
induction time expression of the constructs was higher at 37 
o
C than 30 
o
C and 20 
o
C 
(p ≤ 0.01 and p ≤ 0.0001 respectively). For this construct, the expression temperature 
had a clear effect for the 6 h induction time, with expression increasing as the 
induction temperature was increased.   
 Expression studies in literature report that induction times longer than 6 h are 
associated with low productivity whereas induction times between 4 h and 6 h 
Figure 4.7 Expression of GST-Hst-5-G4S-MBP. CPP fused to MBP were expressed in 
BL21 (DE3) cells at 37 °C, 30 °C and 20 °C for 6 h, 10 h and 24 h with 0.01 mM IPTG. 
The soluble cell lysate was analyzed by Western blotting, with samples normalized by 
culture volume. The Western blot was stained using an (A) HRP-conjugated anti-GST 
antibody. (B) The Western blot data were quantified by densitometry, and the error bars 
represent the standard error of the average of three replicates (N=3).  In our case 
temperature had significant implication (p< 0.001). Refer to Figure A2 in Appendix A for 










presented comparable levels of productivity
40,60,61
. This is consistent with our results 
showing better protein production at shorter times for our many constructs.  It was 
also observed that growth rate reduces with expression temperature reduction from 37 
°C to 25 °C
40,60
. This may explain our improved expression at higher temperatures, 
since an increased growth rate would result in more cells and increase the overall 
level of protein production for a given culture volume. 
 
4.3.3 Expression of GST-MPG-G4S-MBP  
 Similar to the constructs containing SynB and Hst-5 as the CPPs, the 
constructs containing MPG with MBP (GST-G4S-MPG-MBP, 71.1 kDa) expressed at 
all conditions tested (Figure 4.8). Expression of constructs at 37 
o
C was higher than at 
20 
o






4.3.4 Comparison of all MBP constructs at same expression conditions 
 To directly compare expression of the different CPPs with MBP as the cargo 
and MBP with no CPP, samples were induced using the same conditions and 
analyzed on the same Western blot (Figure 4.9). Since 37 
o
C was generally the best 
expression condition for fusions of MBP, expression was induced at 37 
o
C for 10 h. 
GST-MBP was not significantly different from GST-SynB-G4S-MBP and GST-
MPG-G4S-MBP and these constructs were similar in expression (p=0.6045 and 
p=0.9970 respectively). In contrast, GST-Hst-5-G4S-MBP expresses better than both 
SynB constructs (with and without linker) and the MPG construct (p=0.0125, 
Figure 4.8 Expression of GST-MPG-G4S-MBP. CPP fused to MBP were expressed in 
BL21 (DE3) cells at 37 °C, 30 °C and 20 °C for 6 h, 10 h and 24 h with 0.01 mM IPTG. The 
soluble cell lysate was analyzed by Western blotting, with samples normalized by culture 
volume. The Western blot was stained using an (A) HRP-conjugated anti-GST antibody. (B) 
The Western blot data were quantified by densitometry, and the error bars represent the 
standard error of the average of three replicates (N=3). In our case neither temperature nor 
induction time had any significant implication. Refer to Figure A3 in Appendix A for raw 









p=0.0168, p=0.0328). It even expresses at a higher level than MBP alone (p=0.0437).  
Thus, Hst-5 helps in better expression of MBP. 
 These data also show that the CPPs do not reduce expression as has been seen 
before
13
. Further supporting our previous result that the linker does not affect the 
expression of constructs containing GST (Section 4.2), we also found that removing 
the linker from the GST-SynB-G4S-MBP to yield GST-SynB-MBP has no effect on 
expression, as this construct also expresses similarly to GST-MBP (p=0.9940). 
 
 
 Based on the expression data for all of the different MBP constructs, the 
fusion constructs with MBP express very well. This could be due to the fact that MBP 
Figure 4.9 Expression of GST-MBP and all GST-CPP-G4S-MBP constructs. CPP 
fused to MBP were expressed in BL21 (DE3) cells at 37 °C for 10 h with 0.01 mM 
IPTG. The soluble cell lysate was analyzed by Western blotting, with samples 
normalized by culture volume. The Western blot was stained using an (A) HRP-
conjugated anti-GST antibody. (B) The Western blot data were quantified by 
densitometry, and the error bars represent the standard error of the average of three 
replicates (N=2). In our case there was significant difference (p< 0.05). Refer to Figure 





is a very soluble fusion partner and thus enhances expression. MBP has been used 
widely to circumvent inclusion body formation, particularly in E. coli where the 
reduced solubility of recombinant proteins is a serious problem
77
. It has been 
suggested that solubility enhancers may have an innate, inactive chaperone-like 
quality that displays itself as iterative cycles of temporary intramolecular binding to 
cargo such that it averts their self-association and aggregation
61
.   
 Since MBP is known to be a better fusion partner than GST
36, 60,61 
and our 
results show that each of our CPPs express well with MBP, MBP could serve as an 
alternative solubility partner to replace GST at the N-terminus (rather than serving as 
a cargo at the C-terminus). This could lead to enhanced expression for constructs 
containing cargo that are more difficult to express. Proteins like TEV protease and 
GFP fold spontaneously when their tendency to form insoluble aggregates is blocked 




4.4 Expression of CPP constructs with GFP as the cargo 
 CPP-cargo fusion constructs with GFP as the cargo were studied to determine 
promising induction conditions for their expression. GFP is smaller in size than MBP 
and its characteristic fluorescence helps in detection of translocation. Like the 
constructs with MBP, the constructs with GFP had an N-terminal GST, a glycine-
serine linker between the peptide and cargo, and a C-terminal 6XHis tag. Expression 





4.4.1 Expression of GST-SynB-G4S-GFP 
 Expression of GST-SynB-G4S-GFP was inconsistent over several replicate 
experiments, with most experiments resulting in no clear expression of the desired 
product. The expected size of the GST-SynB-G4S-GFP construct is 55.2 kDa and we 
observed a band at this size for each of the induction conditions evaluated in one of 
our experiments (Figure 4.10). However, the band(s) around 25 kDa (degradation 
product) are stronger than the expected band for desired product. 
 
  
 This degradation product could be either the cargo or the fusion partner but it 
is difficult to exactly point out since these are relatively of the same sizes. This blot 
Figure 4.10 Expression of GST-SynB-G4S-GFP. CPP fused to GFP were expressed in 
BL21 (DE3) cells at 37 °C, 30 °C and 20 °C for 6 h, 10 h and 24 h with 0.01 mM IPTG. 
The soluble cell lysate was analyzed by Western blotting, with samples normalized by 
culture volume. The Western blot was stained using an anti-His primary antibody. Refer 
to Figure A4 in Appendix A for raw data. Molecular weight of fusion protein is: GST-







could also mean that this construct just does not express well, and thus it is difficult to 
know the best conditions of expression time and temperatures.  
4.4.2 Expression of GST-Hst-5-G4S-GFP 
 The GST-Hst-5-G4S-GFP constructs (56.1 kDa) showed significant 
expression under all induction conditions, without the degradation observed with 
GST-SynB-G4S-GFP (Figure 4.11). Expression at 30 °C is good but not significantly 
better than any of the other conditions. Temperature though was more significant than 
induction time (p ≤ 0.01).   
 
Figure 4.11 Expression of GST-Hst-5-G4S-GFP. CPP fused to GFP were expressed 
in BL21 (DE3) cells at 37 °C, 30 °C and 20 °C for 6 h, 10 h and 24 h with 0.01 mM 
IPTG. The soluble cell lysate was analyzed by Western blotting, with samples 
normalized by culture volume. The Western blot was stained using an (A) HRP-
conjugated anti-GST antibody. (B) The Western blot data were quantified by 
densitometry, and the error bars represent the standard error of the average of three 
replicates (N=3). In our case temperature had significant implication (p < 0.01).  Refer 
to Figure A6 in Appendix A for raw data. Molecular weight of fusion protein is: GST-










4.4.3 Expression of GST-MPG-G4S-GFP 
 GST-MPG-G4S-GFP constructs ran lower than the size expected when 
expressed at different temperatures of 37 °C, 30 °C and 20 °C and induction times of 
6 h, 10 h and 24 h (Figure 4.12). The blot was stained with 1:8000 anti-GST. The 
expected size of this construct is 56.1 kDa, though the construct didn’t express at the 
size expected.  
 30 
o
C was higher at 6 h than 10 h or 24 h (p ≤ 0.05 & p ≤ 0.01 respectively) 
and 20 
o
C was higher at 6 h and 10 h than 24 h (p ≤ 0.05) whereas none of the other 
conditions were significantly effective. For this construct, the expression temperature 
had a clear effect for the 6 h induction time but comparative higher temperature 
conditions didn’t express at all. In general temperature was more significant (p ≤ 
0.0001) compared to induction time.  
 
Figure 4.12 Expression of GST-MPG-G4S-GFP. CPP fused to GFP were expressed 
in BL21 (DE3) cells at 37 °C, 30 °C and 20 °C for 6 h, 10 h and 24 h with 0.01 mM 
IPTG. The soluble cell lysate was analyzed by Western blotting, with samples 
normalized by culture volume. The Western blot was stained using an (A) HRP-
conjugated anti-GST antibody. (B) The Western blot data were quantified by 
densitometry, and the error bars represent the standard error of the average of three 
replicates (N=3). In our case temperature had significant implication (p < 0.0001).  
Refer to Figure A6 in Appendix A for raw data. Molecular weight of fusion protein is: 








 There might be various reasons for this construct to run at lower size. The 
fusion protein could be truncated and thus not getting fully expressed or just unable to 
be fully expressed. Additionally, some proteins simply run at different sizes than 
expected based on the molecular weight standards. 
 To determine whether the entire MPG fusion was being expressed, a Western 
blot to detect GST-MPG-G4S-GFP was performed again, but the protein was detected 
on the blot using an anti-6XHis antibody instead of the anti-GST antibody used in 
Figure 4.12 (Figure 4.13). The anti-6XHis antibody recognizes the C-terminal tag on 
the protein, so detection by both the anti-GST and anti-6XHis antibody indicates the 
protein contains the expected domains for a full-length fusion. 
 
4.4.4 Comparison of all GFP constructs at same expression conditions 
 Comparison was done between expression of different CPPs and between 
construct with GFP only (Figure 4.13). These were all run on the same blot to be able 
Figure 4.13 Expression of MPG-G4S-GFP with anti-His Ab. CPP fused to GFP were 
expressed in BL21 (DE3) cells at 37 °C for 6 h, 8 h and 10 h with 0.01 mM IPTG. The 
soluble cell lysate was analyzed by Western blotting, with samples normalized by 







to compare between them. 20 °C and 24 h were chosen as the condition to express all 
the fusions of GFP. 
 SynB-G4S-GFP fails to express compared to the GFP only, whereas Hst-5- 
G4S-GFP expresses really well. It is unclear whether MPG-G4S-GFP construct is 
expressing compared than the GFP only and Hst-5- G4S-GFP constructs. 
  
4.5 Expression of CPP constructs with BCCP as the cargo 
 BCCP was chosen as one of the cargoes to study because it is significantly 
smaller (10 kDa) than the other cargoes, which will eventually allow comparison of 
size effects on translocation. Additionally, our lab has previously shown that this 
protein can be produced in E. coli. Previous work in our lab with CPP-BCCP 
constructs containing a C-terminal GST showed that the constructs expressed best at 
Figure 4.14 Expression of all GFP constructs. CPP fused to GFP were 
expressed in BL21 (DE3) cells at 20 °C for 24 h with 0.01 mM IPTG. The 
soluble cell lysate was analyzed by Western blotting, with samples 
normalized by culture volume. The Western blot was stained using an anti-
GST primary antibody. The SynB-G4S-GFP image has been cropped from the 
same blot. This image has been exposed for the same time but failed to 




37 °C, so we focused on this temperature to express the BCCP fusions with the CPPs. 
The GST-CPP-G4S-BCCP constructs were expressed at 37 °C with induction times of 
6 h, 8 h and 24 h (Figure 4.14). Since BCCP is naturally biotinylated by E. coli, biotin 
was supplied during induction to allow detection of biotin as a complementary 
detection method (data not shown).  
 
 GST-SynB-G4S-BCCP expressed at the expected size of 38.2 kDa (Figure 
4.14). It expressed better at 6 h and 8 h than GST-Hst-5-G4S-BCCP (p ≤ 0.05). The 
expression of this construct itself had no significant difference in expression level at 
different times. GST-MPG-G4S-BCCP constructs expressed at the expected size of 
39.1 kDa and expressed significantly better than GST-Hst-5-G4S-BCCP at 6 h, 8 h 
and 24 h (p ≤ 0.05, p ≤ 0.001 & p ≤ 0.05 respectively). The expression of this 
construct showed no significant difference at different induction times. Unlike the 
Figure 4.15 Expression of GST-CPP-G4S-BCCP constructs. CPP fused to BCCP were 
expressed in BL21 (DE3) cells at 37 °C for 6 h, 8 h and 24 h with 0.01 mM IPTG. The 
soluble cell lysate was analyzed by Western blotting, with samples normalized by culture 
volume. The Western blot was stained using an (A) HRP-conjugated anti-His antibody. (B) 
The Western blot data were quantified by densitometry, and the error bars represent the 
standard error of the average of three replicates (N=2). In our case time had no significant 
implication. Molecular weight of fusion protein is: GST-SynB-G4S-BCCP = 38.2 kDa, 







other BCCP fusions, GST-Hst-5-G4S-BCCP failed to express at the expected size 
(39.1 kDa). Bands are present at around 10 – 15 kDa. It is unclear what proteins these 
bands represent, but the size is similar to where BCCP alone runs on a gel.  
 
4.6 Summary of CPP-cargo expression data 
 Expression of CPP-cargo fusions depends on both the cargo and the CPP it is 
fused to. MBP as a cargo consistently expressed well no matter which CPP was fused 
to it. Hst-5 when fused to MBP and GFP expressed well, though the same was not 
true for expression of its fusion to BCCP.  Interestingly, Hst-5 when fused to MBP is 
better than even the protein alone thus showing Hst-5 helps in improving the 
expression of MBP. 
 Fusions with MBP and GFP as cargoes show better expression at 30 °C 
compared to the other temperatures, though no specific temperature or time pattern 
was apparent for the peptides. In general, expression at 37 °C for 6 h and 10 h gave 
good levels of protein expression for many of the fusion proteins, and thus, these 
conditions represent a good starting point when expressing new combinations of 
peptide and cargo.  
 In general, the cargo present in a fusion construct was the best indication of 
the optimal temperature and induction time. When the same peptide was fused to 
different cargoes, the optimal expression conditions changed, while the same cargo 




Chapter 5. Purification and translocation of histatin-5-G4S-GFP 
 
  This chapter focuses on studying the purification and translocation of Hst-5-
G4S-GFP. As described in Chapter 4, fusion constructs containing Hst-5 as the CPP 
expressed well with both MBP and GFP as cargo, and, thus, it is likely that it can be 
produced in large enough quantities to help study their translocation
14
. Hst-5 is 
present in the saliva and thus is safe and also specifically exhibits anti-candidal 
properties
47
, making it a promising CPP for translocating cargo into C. albicans. Due 
to its fluorescence, translocation of GFP into cells can easily be followed using Flow 
cytometry (FC). Because of these characteristics, the Hst-5-G4S-GFP fusion construct 
was selected for purification and evaluation of translocation into C. albicans.  
5.1 Purification of GFP and Hst-5-G4S-GFP 
 Hst-5-G4S-GFP and unconjugated GFP were purified for studying 
translocation into cells using IMAC and IEX. The constructs were expressed in BL21 
(DE3) cells at 37 °C for 6 h, since these conditions yielded high levels of Hst-5-G4S-
GFP in the expression study (Figure 4.11).  
 Unconjugated GFP was purified using IMAC and IEX to obtain a pure 
product (Figure 5.1). Fractions E1, E2 and E3 were combined as the product. The 







 Following expression and recovery of the soluble lysate, IMAC was 
used to bind GST-Hst-5-G4S-GFP to the column and eliminate most 
impurities (Figure 5.2).  
Figure 5.1 Purification of GFP. CPP fused to GFP were expressed in BL21 (DE3) 
cells at 37 °C for 6 h with 0.01 mM IPTG. Coomassie stain was used to estimate 
purity of the fusion proteins. The crude soluble lysates, washes and elution from 
immobilized metal affinity chromatography are shown. The expected sizes of the 
proteins are 27 kDa for GFP, 56.055 kDa for Hst-5-G4S-GFP. The crude soluble 
lysate (L) contains the whole construct; flow through (FT) doesn’t bind to the 
column and so flows through, Wash (W), Elutes (E1, E2 and E3) are eluted using a 






 GST-Hst-5-G4S-GFP contained a Factor Xa enzyme cleavage site between the 
GST and the Hst-5, so Factor Xa was applied to the IMAC column to remove GST 
while Hst-5-G4S-GFP remained bound (Figure 5.2). The protein lysate was applied to 
the column and Factor Xa was added to the column after washing. The column was 
shaken overnight for over 16 h with the Factor Xa for the cleavage to occur. 
Following Factor Xa removal, the sample contained substantial fusion protein with 
GST still attached (56.1 kDa). This indicates that we will need to improve the 
cleavage conditions in the future to achieve better removal of the GST. However, our 
desired product without the GST was present (30.1 kDa), so we continued the 
purification process with IEX to remove the fusion with uncleaved GST (Figure 5.3). 
The GST-Hst-5-G4S-GFP can be separated from the Hst-5-G4S-GFP by ion 
Figure 5.2 Purification of Hst-5-G4S-GFP with cleaved Factor Xa. CPP fused to 
GFP were expressed in BL21 (DE3) cells at 37 °C for 6 h with 0.01 mM IPTG. 
Coomassie stain was used to estimate purity of the fusion proteins. The crude 
soluble lysates, washes and elution from immobilized metal affinity chromatography 
are shown. On-column cleavage with Factor Xa to remove GST was done. The 
expected sizes of the proteins are 30.1 kDa for our protein. The crude soluble lysate 
(L) contains the whole construct; flow through (FT) doesn’t bind to the column and 
so flows through, Wash (W), Elutes (E6 contains our un-cleaved product at around 
56 kDa and our cleaved protein at around 25 kDa) are eluted using a gradient of 









exchange, though the purity isn’t perfect. The desired protein is present at a 
reasonable purity in fractions E2 and E3, so these fractions were combined as the 
purified Hst-5-G4S-GFP (63 % purity). 
 
 Even without optimization, the purification process produced sufficient 
protein for translocation studies. The yield of Hst-5-G4S-GFP was 36 mg per liter of 
culture. In a previous study, Gong et al. purified NPFSD-G4S-GFP and pVEC-G4S-
GFP produced in E. coli with no GST as an expression partner and only achieved 
yields of 0.264 ± 0.013 mg protein/Liter of culture and 0.159 ± 0.053 mg 
protein/Liter of culture, respectively. The yield of Hst-5-G4S-GFP in this work was 
two orders higher in magnitude than these earlier yields. This substantial difference in 
expression is likely due to a combination of Hst-5 expressing better than the peptides 
NPFSD and pVEC and to the addition of the soluble fusion partner GST in our 
Figure 5.3 Purification of Hst-5-G4S-GFP constructs. CPP fused to GFP were 
expressed in BL21 (DE3) cells at 37 °C for 6 h with 0.01 mM IPTG. Coomassie stain 
was used to estimate purity of the fusion proteins. The crude soluble lysates, washes 
and elution from anion-exchange chromatography are shown. The expected sizes of 
the proteins are 27 kDa for GFP, 56.1 kDa for Hst-5-G4S-GFP – without GST our 









constructs. These higher yields of CPP-cargo fusion will facilitate studying 
translocation into cells. By evaluating and optimizing our purification protocols, we 
will be able to further improve both the purity and the yield of our fusion. One key 
aspect will be optimizing the amount of Factor Xa to fully cleave the GST from our 
fusion partner, which has the potential to substantially increase the yield and purity of 
our desired construct without any additional modifications to the protocol.  
5.2 Translocation of CPPs fused to cargoes into C. albicans  
 We showed we could purify Hst-5-G4S-GFP fusion protein with a good yield 
using straightforward purification steps. As the main reason of creating the CPP-GFP 
fusion is to utilize CPPs to help deliver cargoes into fungal cells, we next explored the 
intracellular delivery of this purified fusion construct into the important fungal 
pathogen C. albicans.  
 To screen the CPPs for translocation into Candida species, C. albicans cells 
were incubated with both Hst-5-G4S-GFP and GFP lacking a CPP. We examined and 
quantified translocation of the proteins using flow cytometry. All single C. albicans 
cells were selected, and the percentage of fluorescence-positive cells was used to 
evaluate the GFP delivery efficacy. About 3% of the fungal cells exhibited a green 
fluorescence signal (Figure 5.4c) when treated with 0.5 µM purified Hst-5-G4S-GFP 
fusion protein (Figure 5.4). (This concentration reflects the total protein concentration 
of the sample and does not take the purity into consideration). When the 
concentration was reduced to 0.05 µM Hst-5-G4S-GFP, no significant uptake was 




dependence is expected based on previous data for CPP delivery of fluorescein 
31
.  
The study here has been done with lower end of concentration (0.5 µM vs. 1 µM in 
literature). We would expect higher translocation with higher concentration based on 
studies by Gong et al., 2017. An interesting fact to note here is that fact that we are 
using a large protein and not the small-molecule fluorescein when comparing our 
results. 
 To further explore the effect of the Hst-5-G4S-GFP fusion protein on C. 
albicans, we evaluated the permeability of the cells after treatment with the fusion 
protein using PI. Cells are normally impermeable to PI, but PI fluorescence can be 
detected inside cells with destabilized membranes. Destabilization can occur with cell 
death or with pore formation on the membrane
78
. We observed substantially low,  
<1% PI-positive cells following incubation with Hst-5-G4S-GFP, indicating the 
fusion protein does not significantly affect the membrane integrity. This was similar 
to the level of toxicity of GFP alone. This likely indicates that Hst-5 does not have 
antifungal activity under these conditions. This is consistent with a previous study 
about Hst-5 (with no cargo) that showed no significant antifungal activity towards C. 
albicans for Hst-5 concentrations below 1.63 μM
47








Figure 5.4 Cellular Uptake studies. Flow cytometry was used to quantify 
translocation and membrane permeabilization in C. albicans for (a) cells incubated 
with buffer only and no stain, (b) cells incubated with GFP and PI, (c) cells with 0.5 
µM Hst-5-G4S-GFP and PI, and (d) cells incubated with 0.05 µM Hst-5-G4S-GFP. 
The translocation studies were done for 3 replicates but a, b, c and d is a 
representative set of data. Average data for each group are found in Table 5.1. Only 
single cells were selected for analysis. In each plot, quadrant Q1 represents cell that 
are PI +/GFP -, Q2 represents those that are PI +/GFP +, Q3 represents those that 
are PI -/GFP +, and Q4 represents those that are PI -/GFP -. The numbers under 
each quadrant label provide the percentage of cells in the experiment that fall into 
each quadrant. The quadrant boundaries were chosen such that there were no cells 
with translocation of GFP only. Each cell in the sample is represented by a dot, and 
the color on the dot plots indicate the density of cells (red represents high density and 











Table 6. Cellular Uptake studies using FLOWJO 
*Values are given as averages of 2 biological replicates with standard error 
 
 These results show that Hst-5 (an antimicrobial peptide) can be used to deliver 
protein cargo.  Hst-5 shows specificity for fungal cells, and thus is promising to be 
used as a specific delivery tool. Increasing concentration of fusion is likely to 
improve results based on the results above and previous work.  To understand how 
the peptide and cargo are translocated and any intracellular effect of the cargo and the 
CPP, further studies will need to be done. Additionally, similar studies with other 
CPPs or cargoes will help better understand the capabilities and limitations of CPP-





Concentration of the Hst-5-
GFP (µM) 
% GFP-positive* % of cells with GFP that 
are dead 
0.5 3.12±2.46 0.365±0.233 




Chapter 6. Conclusions and future work 
 
6.1 Conclusion 
 This study was done to increase the expression and production and form a 
generalized platform for expression of CPP-cargo fusions. We showed that 
recombinant expression technology can be used to conjugate CPPs and cargo proteins 
in vivo.  
 We tried to improve recombinant production of CPPs as fusions to protein 
cargo by considering numerous variables: induction temperatures, induction times, 
CPPs, cargoes, linkers and a soluble partner. We were able to express fusion proteins 
with different combinations of CPPs and cargoes. In general, induction at 37 °C for 6 
h or 10 h resulted in comparatively high levels of expression; these conditions would 
be a good starting point for future studies of new CPPs or cargo proteins. Hst-5 as a 
CPP expressed well with both MBP and GFP but failed to express at the expected 
size with BCCP as a cargo.  
 We were able to produce sufficient Hst-5-G4S-GFP for performing a 
translocation experiment in C. albicans. At a concentration of 10 µM, Hst-5-G4S-
GFP translocated into C. albicans cells with minimal killing activity.  
 Now that we have a better understanding of conditions that improve 
expression of CPP-cargo fusions, we can focus on improving purification protocols to 




fusions will be needed to for more complete studies of their biological activity and 
mechanisms of translocation and their functions once inside the target cell. 
6.2 Path forward 
6.2.1 Toxicity of CPPs toward Candida cells  
 To study the toxicity of CPPs toward C. albicans, we incubated the cells with 
serial dilutions of the GFP and Hst5-G4S-GFP. Little to no antifungal activity could 
be detected for CPP fusions that exhibited translocation (Chapter 5). The PI data has 
already shown no killing activity but a standard antifungal assay can be done similar 
to what is used for Candida to further show the killing activity. 
 Though toxicity of CPPs is required for delivering antifungal molecules, CPPs 
can also act as delivery vehicles for non-toxic biomolecules or the CPPs may be toxic 
to the target cells – thus lower toxicity is needed. Thus the knowledge of toxicity of 
CPPs and their attached cargo are of prime importance. 
 This leads us to our second future goal of understanding function of CPPs 
inside cells.  
6.2.2 CPPs and their interaction with fungal cells 
To understand how the peptide acts inside the cell and how long it is actively 
delivering the cargo, further studies will need to be done that allows us to know the 
cellular localization of the fusion construct tested in Chapter 5. Further studies also 





 At different concentrations of the fusions, the uptake has shown to be varied, 
and thus its needs to be seen how the cells behave at even higher concentrations of the 
peptide if the cells retain their vacuole. In yeast, vacuoles are the most acidic part of 




 It has been shown for the results for pVEC
31
 where flow cytometry was used 
to evaluate the intracellular trafficking in C. albicans and C. glabrata and there was 
substantial uptake. Intracellular trafficking through vacuoles has also been detected 
for all peptides studied that suggest that vacuoles are important in the translocation 
mechanism of CPPs for fungal cells. Mechanisms for translocation of the fusion 
protein into fungal cells also need to be explored.  
 
6.2.3 Replacement of GST by MBP 
 As is well known MBP is a better soluble fusion partner than GST
43,60
, so a 
next logical step would be to replace GST at the N-terminus by MBP thus enhancing 
expression of fusion cargoes. One limitation, though, is that MBP binds to an amylose 
resin which is an expensive technique. 
 
6.2.4 Design changes in CPPs to make cargo delivery better 
 Specific amino acids can be changed/mutated in the sequences of the CPPs 




done by Gong et al.). These modified sequences along with the combination of right 
cargoes and better soluble partners might help increase expression and delivery of 
multiple constructs can be studied (as opposed to only a single construct studied in 
this thesis.  
 
6.2.5 Detection of fusions inside cells 
 In the present work, we have used a fluorescent cargo to study translocation. 
Very limited number of fluorescent cargoes exists and we would like to extend our 
studies to look at other cargoes for e.g., MBP and BCCP. To be able to do this, we 
need a method(s) to detect non-fluorescent proteins. The expression of the fusion 
construct can be tested in C. albicans by using Western Blot and/or ELISA and the 
efficacy of the methods could be tested using GFP constructs, since we already have a 










S-MBP raw data. The y-axis represents the volume 
(intensity) and the X-axis represents the induction time in hours 
















     
  
 
Figure A2 Hst-5-G4S-MBP raw data. The Y-axis represents the volume 
(intensity) and the X-axis represents the induction time in hours 



















S-MBP raw data. The Y-axis represents the volume 
(intensity) and the X-axis represents the induction time in hours 


























S-GFP raw data. The Y-axis represents the volume 
(intensity) and the X-axis represents the induction time in hours 





















S-GFP raw data. The Y-axis represents the volume 
(intensity) and the X-axis represents the induction time in hours 




















S-BCCP raw data. The Y-axis represents the volume 
(intensity) and the X-axis represents the induction time in hours 


















Figure A8 All MBP constructs raw data. The Y-axis represents the 
volume (intensity) and the X-axis represents the induction time in hours. 
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